Primary efficacy and safety of letetresgene autoleucel (lete-cel; GSK3377794) pilot study in patients with advanced and metastatic myxoid/round cell liposarcoma (MRCLS).

标题
Primary efficacy and safety of letetresgene autoleucel (lete-cel; GSK3377794) pilot study in patients with advanced and metastatic myxoid/round cell liposarcoma (MRCLS).
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 40, Issue 16_suppl, Pages 11500-11500
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2022-06-07
DOI
10.1200/jco.2022.40.16_suppl.11500

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started